Careteq Ltd Q4 FY26 Activities Report & Appendix 4C
Key points
- Careteq's balance sheet strengthened following EHS sale and capital raising
- HMR Referrals strategic reset underway
- ASX confirmed continued quotation of Careteq's securities
- Completed Tranche 2 capital raising of $2.07m
- Strong cash balance at $3.2m with no debts
Full summary
Careteq Ltd (ASX: CTQ) reported its Q4 FY26 activities, highlighting a strengthened balance sheet following the sale of Embedded Health Solutions (EHS) and a successful capital raising. The company is now focused on its HMR Referrals strategic reset, which includes AI-enablement, pharmacist recruitment, and strategic collaborations. Careteq also announced the appointment of Mr Leonard Math as Non-Executive Director. The company's cash position improved to $3.2m, up from $837,000 at the end of the previous quarter, reflecting proceeds from EHS disposal and capital raising. Operating costs were reduced to ~$250k per quarter, excluding one-off costs.
Summary generated by a large language model. Please interpret with care.